These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 33234096)
1. Bioluminescent:Fluorescent Trypanosoma cruzi Reporter Strains as Tools for Exploring Chagas Disease Pathogenesis and Drug Activity. Taylor MC; Ward AI; Olmo F; Francisco AF; Jayawardhana S; Costa FC; Lewis MD; Kelly JM Curr Pharm Des; 2021; 27(14):1733-1740. PubMed ID: 33234096 [TBL] [Abstract][Full Text] [Related]
2. Exploiting Genetically Modified Dual-Reporter Strains to Monitor Experimental Trypanosoma cruzi Infections and Host-Parasite Interactions. Taylor MC; Francisco AF; Jayawardhana S; Mann GS; Ward AI; Olmo F; Lewis MD; Kelly JM Methods Mol Biol; 2019; 1955():147-163. PubMed ID: 30868525 [TBL] [Abstract][Full Text] [Related]
3. Expanding the toolbox for Trypanosoma cruzi: A parasite line incorporating a bioluminescence-fluorescence dual reporter and streamlined CRISPR/Cas9 functionality for rapid in vivo localisation and phenotyping. Costa FC; Francisco AF; Jayawardhana S; Calderano SG; Lewis MD; Olmo F; Beneke T; Gluenz E; Sunter J; Dean S; Kelly JM; Taylor MC PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006388. PubMed ID: 29608569 [TBL] [Abstract][Full Text] [Related]
4. Ward AI; Lewis MD; Khan AA; McCann CJ; Francisco AF; Jayawardhana S; Taylor MC; Kelly JM mBio; 2020 Aug; 11(4):. PubMed ID: 32753495 [TBL] [Abstract][Full Text] [Related]
5. A new experimental model for assessing drug efficacy against Trypanosoma cruzi infection based on highly sensitive in vivo imaging. Lewis MD; Francisco AF; Taylor MC; Kelly JM J Biomol Screen; 2015 Jan; 20(1):36-43. PubMed ID: 25296657 [TBL] [Abstract][Full Text] [Related]
6. Drug-cured experimental Trypanosoma cruzi infections confer long-lasting and cross-strain protection. Mann GS; Francisco AF; Jayawardhana S; Taylor MC; Lewis MD; Olmo F; de Freitas EO; Leoratti FMS; López-Camacho C; Reyes-Sandoval A; Kelly JM PLoS Negl Trop Dis; 2020 Apr; 14(4):e0007717. PubMed ID: 32302312 [TBL] [Abstract][Full Text] [Related]
7. A panel of phenotypically and genotypically diverse bioluminescent:fluorescent Trypanosoma cruzi strains as a resource for Chagas disease research. Olmo F; Jayawardhana S; Khan AA; Langston HC; Francisco AF; Atherton RL; Ward AI; Taylor MC; Kelly JM; Lewis MD PLoS Negl Trop Dis; 2024 May; 18(5):e0012106. PubMed ID: 38820564 [TBL] [Abstract][Full Text] [Related]
8. A novel nanoluciferase-based system to monitor Trypanosoma cruzi infection in mice by bioluminescence imaging. Silberstein E; Serna C; Fragoso SP; Nagarkatti R; Debrabant A PLoS One; 2018; 13(4):e0195879. PubMed ID: 29672535 [TBL] [Abstract][Full Text] [Related]
9. Intracellular DNA replication and differentiation of Trypanosoma cruzi is asynchronous within individual host cells in vivo at all stages of infection. Taylor MC; Ward A; Olmo F; Jayawardhana S; Francisco AF; Lewis MD; Kelly JM PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008007. PubMed ID: 32196491 [TBL] [Abstract][Full Text] [Related]
10. Limited Ability of Posaconazole To Cure both Acute and Chronic Trypanosoma cruzi Infections Revealed by Highly Sensitive In Vivo Imaging. Francisco AF; Lewis MD; Jayawardhana S; Taylor MC; Chatelain E; Kelly JM Antimicrob Agents Chemother; 2015 Aug; 59(8):4653-61. PubMed ID: 26014936 [TBL] [Abstract][Full Text] [Related]
11. Bioluminescence imaging of chronic Trypanosoma cruzi infections reveals tissue-specific parasite dynamics and heart disease in the absence of locally persistent infection. Lewis MD; Fortes Francisco A; Taylor MC; Burrell-Saward H; McLatchie AP; Miles MA; Kelly JM Cell Microbiol; 2014 Sep; 16(9):1285-300. PubMed ID: 24712539 [TBL] [Abstract][Full Text] [Related]
13. Incomplete Recruitment of Protective T Cells Is Associated with Trypanosoma cruzi Persistence in the Mouse Colon. Ward AI; Lewis MD; Taylor MC; Kelly JM Infect Immun; 2022 Feb; 90(2):e0038221. PubMed ID: 34780279 [TBL] [Abstract][Full Text] [Related]
14. Comparing in vivo bioluminescence imaging and the Multi-Cruzi immunoassay platform to develop improved Chagas disease diagnostic procedures and biomarkers for monitoring parasitological cure. Francisco AF; Saade U; Jayawardhana S; Pottel H; Scandale I; Chatelain E; Liehl P; Kelly JM; Zrein M PLoS Negl Trop Dis; 2022 Oct; 16(10):e0010827. PubMed ID: 36190992 [TBL] [Abstract][Full Text] [Related]
15. Central role of metabolism in Trypanosoma cruzi tropism and Chagas disease pathogenesis. Liu Z; Ulrich vonBargen R; McCall LI Curr Opin Microbiol; 2021 Oct; 63():204-209. PubMed ID: 34455304 [TBL] [Abstract][Full Text] [Related]
16. Trypanosoma cruzi genetic diversity: Something new for something known about Chagas disease manifestations, serodiagnosis and drug sensitivity. Zingales B Acta Trop; 2018 Aug; 184():38-52. PubMed ID: 28941731 [TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo high-throughput assays for the testing of anti-Trypanosoma cruzi compounds. Canavaci AM; Bustamante JM; Padilla AM; Perez Brandan CM; Simpson LJ; Xu D; Boehlke CL; Tarleton RL PLoS Negl Trop Dis; 2010 Jul; 4(7):e740. PubMed ID: 20644616 [TBL] [Abstract][Full Text] [Related]
18. In vivo imaging of mice infected with bioluminescent Trypanosoma cruzi unveils novel sites of infection. Henriques C; Henriques-Pons A; Meuser-Batista M; Ribeiro AS; de Souza W Parasit Vectors; 2014 Mar; 7():89. PubMed ID: 24589192 [TBL] [Abstract][Full Text] [Related]
19. Ward AI; Olmo F; Atherton RL; Taylor MC; Kelly JM Open Biol; 2020 Dec; 10(12):200261. PubMed ID: 33321060 [TBL] [Abstract][Full Text] [Related]